69942-12-7

69942-12-7 structure

Name: N-Boc-DL-serine methyl ester
Chemical Name: Methyl 2-((tert-butoxycarbonyl)amino)-3-hydroxypropanoate
CAS Number: 69942-12-7
Molecular Formula: C₉H₁₇NO₅
Molecular Weight: 219.235
Catalog: Biochemical Amino acids and their derivatives Serine derivative
Create Date: 2018-05-26 08:00:00
Modify Date: 2026-07-17 20:46:44
N-BOC-DL-serine methyl ester is a Serine derivative. N-BOC-DL-serine methyl ester is used for the synthesis of α,β-dehydro-α-amino acid. N-BOC-DL-serine methyl ester is also used for the synthesis of anti-cancer agent, such as quinazolinone derivative that inhibits PI3K activity, and tricyclic pyrolopyranopyridines that inhibits protein kinase activity[1][2][3].

Name	Methyl 2-((tert-butoxycarbonyl)amino)-3-hydroxypropanoate
Synonyms	methyl 3-hydroxy-2-[(2-methylpropan-2-yl)oxycbonylamino]propanoate N-[(1,1-DiMethylethoxy)carbonyl]serine Methyl Ester Serine, N-[(1,1-dimethylethoxy)carbonyl]-, methyl ester 3-hydroxy-2-[[(2-methylpropan-2-yl)oxy-oxomethyl]amino]propanoic acid methyl ester methyl N-(tert-butoxycbonyl)serinate methyl 3-hydroxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate Boc-DL-Ser-Ome-OH DL-Serine, N-[(1,1-diMethylethoxy)carbonyl]-, Methyl ester 2-[(tert-Butoxycbonyl)amino]-3-hydroxypropionic acid methyl ester Methyl N-(tert-butoxycarbonyl)serinate Methyl N-{[(2-methyl-2-propanyl)oxy]carbonyl}serinate Boc-DL-Serine methyl ester

Description	N-BOC-DL-serine methyl ester is a Serine derivative. N-BOC-DL-serine methyl ester is used for the synthesis of α,β-dehydro-α-amino acid. N-BOC-DL-serine methyl ester is also used for the synthesis of anti-cancer agent, such as quinazolinone derivative that inhibits PI3K activity, and tricyclic pyrolopyranopyridines that inhibits protein kinase activity[1][2][3].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Others >> Others
References	[1]. Yang Yongqing, et al. Method for synthesizing α,β-dehydro-α-amino acid. Patent CN105037210. [2]. Wu Chengde, et al. Preparation of quinazolinone derivatives useful as PI3Kα inhibitors for the treatment of cancer. Patent WO2019091476. [3]. Pastor Fernandez, et al. Preparation of tricyclic pyrolopyranopyridines as protein kinase inhibitors. Patent WO2017033019.

Hazard Codes	Xi